Systemic lupus erythematosus (SLE, MIM152700) is an autoimmune disease characterized by self-reactive antibodies resulting in systemic inflammation and organ failure. TNFAIP3, encoding the ubiquitin-modifying enzyme A20, is an established susceptibility locus for SLE. By fine mapping and genomic re-sequencing in ethnically diverse populations, we fully characterized the TNFAIP3 risk haplotype and identified a TT>A polymorphic dinucleotide (deletion T followed by a T to A transversion) associated with SLE in subjects of European (P = 1.58 × 10 −8 , odds ratio = 1.70) and Korean (P = 8.33 × 10 −10 , odds ratio = 2.54) ancestry. This variant, located in a region of high conservation and regulatory potential, bound a nuclear protein complex composed of NF-kB subunits with reduced avidity. Further, compared with the non-risk haplotype, the haplotype carrying this variant resulted in reduced TNFAIP3 mRNA and A20 protein expression. These results establish this TT>A variant as the most likely functional polymorphism responsible for the association between TNFAIP3 and SLE. TNFAIP3, the tumor necrosis factor alpha inducible protein 3 gene, encodes the ubiquitin-modifying enzyme A20, a key regulator of NF-κB activity downstream of tumor necrosis factor alpha (TNFα), toll-like receptor (TLR), interleukin 1 receptor (IL1R) and nucleotidebinding oligomerization domain containing 2 (NOD2) [1] [2] [3] [4] . The importance of A20 in restricting NF-κB has been shown in A20-deficient mice, which develop systemic organ inflammation and die within 6 weeks of birth 2, 3 , and in mice with B lymphocyte-specific A20 ablation, which develop lupus-like autoimmunity 5 . In humans, genetic
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VOLUME 43 | NUMBER 3 | MARCH 2011 Nature GeNetics l e t t e r s studies have suggested a role for TNFAIP3 in susceptibility to complex genetic autoimmune disorders [6] [7] [8] , including SLE [9] [10] [11] [12] .
Genetic association between the TNFAIP3 region and SLE suggest that alterations in activity and/or expression of TNFAIP3-encoded A20 influence SLE pathophysiology [9] [10] [11] . Independent genetic associations of the TNFAIP3 region with SLE in individuals of European ancestry have been localized to a region 185 kb upstream of TNFAIP3 that was previously associated with rheumatoid arthritis 6, 7 , a region 249 kb downstream of TNFAIP3 and a 109-kb haplotype spanning the TNFAIP3 coding region [9] [10] [11] that includes a suggested causal coding variant in exon 3 (rs2230926, T>G, p.Phe127Cys) that reduces the ability of A20 to attenuate NF-κB signaling 10 . In this report, we fully characterize the TNFAIP3 risk haplotype, including the TNFAIP3 coding region, in five ethnically diverse populations and identify a previously unreported functional polymorphism that is most likely responsible for association with human SLE.
We studied 127 SNPs in the TNFAIP3 region on 6q23 and 347 ancestry-informative markers (AIMs) in five ethnically diverse populations ( Table 1 and Supplementary Table 1 ) and evaluated differences in linkage disequilibrium (LD) to narrow the associated DNA segment. After applying quality control measures and adjusting for admixture within and across populations (Supplementary Table 2) , we analyzed 8,341 independent affected individuals (cases) and 7,476 independent controls (Table 1) for 113 TNFAIP3 SNPs and 262 AIMs. We also imputed genotypes for SNPs from the 1000 Genomes Project and Phase III HapMap reference panels, resulting in a minimum of 274 additional SNPs for each population (Supplementary Table 3) .
Adjusting for sex and global ancestry in European-ancestry and Asian populations, single-marker logistic regression analyses of SNPs spanning the TNFAIP3 coding region showed association far below a Bonferroni-corrected P < 1 × 10 −4 (Fig. 1a,b) . We saw peak associations in individuals of European ancestry and Asians at markers rs6932056 (P = 3.92 × 10 −10 , odds ratio (OR) = 1.78, 95% CI 1.49-2.13) and rs4896303 (P = 6.84 × 10 −11 , OR = 2.35, 95% CI 1.82-3.03) 38 kb and 30 kb downstream of TNFAIP3, respectively. We saw only modest association in the European-ancestry population in the previously reported region 9,10 185 kb upstream of TNFAIP3 (Fig. 1a) . Korean subjects comprised 71% of our Asian cohort and, when analyzed independently, showed no marked differences in association from the full Asian dataset (Fig. 1c) ; thus, subsequent analyses focused only on the more homogeneous Korean subset.
In total, 28 SNPs (P < 1 × 10 −4 ) in both the European-ancestry and Korean populations defined the TNFAIP3 risk haplotype (Table 2) .
Notably, no convincing evidence for association with TNFAIP3 was seen in the African American, African American-Gullah or Hispanic population (Supplementary Fig. 1a-c) .
To assess whether differences in the LD structure between the European-ancestry and Korean populations (Supplementary Fig. 2 ) could reduce the size of the TNFAIP3 risk segment, we compared haplotypes (frequency ≥1%) formed by the SNPs shown in Table 2 . In individuals of European ancestry, we observed a single 101-kb risk haplotype (P = 8.71 × 10 −10 ; Fig. 2a , European-ancestry haplotype 2). Three segments of this haplotype carry minor alleles absent from the non-risk haplotypes, suggesting they might harbor the causal variant. In Koreans, we observed two primary risk haplotypes with P = 4.11 × 10 −5 and P = 2.27 × 10 −6 ( Fig. 2a ; Korean haplotypes 2 and 3, respectively). These two risk haplotypes shared minor alleles not present on the non-risk haplotype from marker rs5029937 to rs61117627, thus reducing the TNFAIP3 risk interval to this 48.5-kb segment.
Re-sequencing nine TNFAIP3 risk chromosomes from seven carriers of European ancestry (two homozygotes and five heterozygotes) did not identify any additional SNPs not already accounted for in our analyses (Online Methods). However, we did find a previously unreported single base deletion at chromosome 6 position 138,271,732 (hg18) present on all nine risk chromosomes (Supplementary Fig. 3) . Notably, this deletion polymorphism was located adjacent to SNP To determine the segment of the risk haplotype that accounted for the largest portion of the association signal, we performed a conditional association analysis. Conditioning on the SNP on chromosome 6 at position 138,271,733 or its proxy SNP, rs7749323 (r 2 ≥ 0.97), for both European-ancestry and Korean populations reduced the association signal to baseline (Fig. 2b,c) . However, conditioning on rs2230926, a coding variant in exon 3 (p.Phe127Cys) and a putative causal variant revealed residual association in the region 31.2 kb downstream most prominently in individuals of European ancestry ( Fig. 2b ) and, to a lesser extent, in Koreans (Fig. 2c) . These results suggested that the variant responsible for association with SLE was likely to be located in the 16.3-kb region extending from rs7752903 to rs61117627.
To assess the functional potential of the nine risk variants (eight SNPs and one deletion) present on the 16.3-kb TNFAIP3 risk segment defined by our previous analyses, we evaluated the region with the UCSC Genome Browser (see URLs) to determine overlap between variants and genomic regulatory elements ( Supplementary  Fig. 5a ). The TT>A polymorphic dinucleotide is located in a region of high mammalian conservation (17-way vertebrate conservation 13 ), high regulatory potential (7X Regulatory Potential, ESPERR 14 ) and overlap with DNase hypersensitivity and transcription factor binding signals, as well as a region of enhancer activity bearing the H3K27Ac epigenetic mark 15 (Supplementary Fig. 5a ). Eight transcription factors produced ChIP-seq signals in the vicinity of this variant, with the strongest signals produced by early B-cell factor (EBF), B-cell CLL/lymphoma 11A (BCL11A) and NF-κB (ref. 16) (Supplementary  Fig. 5b ). In contrast, the remaining variants showed substantially less overlap with regulatory elements, thus pointing to the TT>A variant as the prime candidate functional variant responsible for association with SLE.
We sought further evidence in support of the TT>A polymorphic dinucleotide by genotyping both African American and African American-Gullah cases and controls (Online Methods). Neither of these populations showed association of the TNFAIP3 region with SLE, and they would therefore not be expected to carry the variants of interest. In all African American samples evaluated (n = 2,252), we observed this variant only 24 times (one copy each in 13 cases and 11 controls) for an overall allele frequency of 0.53%, which approximates that expected due to European admixture (Online Methods). Furthermore, we did not detect the TT>A variant in any of the African American-Gullah samples (n = 243), a population with low European admixture (~3.5%) 17 . We estimate that our power to detect an association with the TT>A variant in this African American sample collection is only 0.8% given a type I error of 0.0001 and an odds ratio of 1.7. These results suggest that the TT>A dinucleotide polymorphism is present in European and Asian chromosomes and that the low allele frequency in African Americans resulted in our inability to show association in this population. 
l e t t e r s
To test functional differences in nuclear protein binding conferred by the TT>A polymorphic dinucleotide, we evaluated oligonucleotide probes containing this variant or wild-type sequences using an electrophoretic mobility shift assay (EMSA). In nuclear extracts from independent monocyte cell lines (THP1 and U937), we observed a differential intensity of shifted bands (Fig. 3a) , suggesting that the TT>A variant is important in mediating nuclear protein binding. Using antibodies specific to subunits of the NF-κB transcription factor (p50, p65 and cREL), we found that NF-κB was a major component of the DNA nuclear protein complex (Fig. 3b) . The densitometric measurement of the shifted band intensity from multiple independent experiments showed statistically significant differences between the TT>A and wild-type cells for the THP-1 extracts at P = 0.0076 (n = 6; Fig. 3c ). U937 extracts also showed a difference at the less stringent level of P = 0.09, likely due to the smaller number of observations in U937 cells (n = 3; Fig. 3d) .
As altered binding of NF-κB to the regulatory region containing the TT>A polymorphic dinucleotide could influence TNFAIP3 Haplotype  rs2788289  rs670369  rs80126770  rs9494883  rs9494885  rs7753873  rs7767264  rs72063345  rs5029924  rs5029926  rs5029928  rs3757173  rs5029930  rs719149  rs719150  rs5029937  rs5029939  rs2230926  rs7752903  rs9494894  rs57427648  rs7749323  rs77000060  rs6932056  rs61117627 figure. (c,d) We performed densitometric quantification of nuclear protein binding in independent experiments for THP1 cells (c) and U937 cells (d) using optimal concentrations of nuclear extract. (e,f) Expression of TNFAIP3 transcripts were evaluated from CEU, CHB and JPT populations (AA, n = 2; AG, n = 24; GG, n = 115) (e) and compared to the YRI population (AG, n = 6; GG, n = 54) (f) using a one-way ANOVA and unpaired t-test, respectively. (g,h) We compared A20 protein expression from cell lines of European-ancestry subjects (AA, n = 2; AG, n = 5; GG, n = 5) (g) to African-American subjects (AG, n = 10, GG, n = 9) (h) using one-way ANOVA and unpaired t-test, respectively. l e t t e r s expression, we used expression data generated from transformed B-cell lines in samples from 201 unrelated HapMap individuals 18 (see URLs) to test this possibility. We pooled the genotypes for rs7749323 from HapMap European (CEU), Chinese (CHB) and Japanese (JPT) subjects, as our data confirmed that rs7749323 is a perfect proxy of the TT>A variant in these populations, and we compared TNFAIP3 mRNA expression to that of the HapMap Yoruba (YRI) samples. These results showed a significant decrease in TNFAIP3 mRNA expression with the number of risk alleles (A) in the combined sample (P = 0.0001, one-way analysis of variance (ANOVA); Fig. 3e ) compared to the YRI samples (P = 0.2352, two-tailed t-test; Fig. 3f ). To confirm these results, we evaluated basal A20 expression in an independent set of EBV-transformed cell lines by protein blotting. Similar to the mRNA expression results, we found decreased expression of A20 protein as a function of the number of rs7749323 risk alleles in individuals of European ancestry (P = 0.0068, one-way ANOVA; Fig. 3g ) compared to cell lines from African Americans (P = 0.8078, two-tailed t-test; Fig. 3h ). These results support the hypothesis that regulatory polymorphisms present on the TNFAIP3 risk haplotype, such as the TT>A polymorphic dinucleotide, influence A20 expression. In summary, we have comprehensively characterized the genetic variation present on the TNFAIP3 risk haplotype and have identified a TT>A dinucleotide as the best candidate polymorphism responsible for the association of the TNFAIP3 region with SLE in subjects of European and Korean ancestry. The lack of significant association in African American, African American-Gullah and Hispanic populations is proportional to the power to detect the Europeanderived TT>A variant present at frequencies consistent with European admixture (0.53%, unobserved, and 2.9%, respectively). The TT>A dinucleotide variant, 42 kb downstream of the TNFAIP3 promoter, is located in a genomic region of high conservation and regulatory potential and may influence TNFAIP3 expression by altering the binding of transcription factors, one of which is NF-κB, in response to pro-inflammatory signals.
In addition to the TT>A polymorphic dinucleotide and the rs2230926 T>G (p.Phe127Cys) exon 3 coding variant, another TNFAIP3 functional variant was recently reported in SLE through genetic association in 217 African American cases 19 . This variant, rs5029941 C>T, defines a rare African-derived protective haplotype (P = 0.027) and encodes a p.Ala125Val substitution, two amino acid residues from p.Phe127Cys 19 . Functionally, the p.Ala125Val polymorphism resulted in defects in A20-mediated deubiquitination 19 . However, our results from a larger set of African American SLE cases (n = 1527) failed to support a role for rs5029941 (P = 0.223; Supplementary Table 4) in SLE susceptibility among African Americans.
Although rare variants may influence genetic associations with the TNFAIP3 region, we are confident that we have captured all common variants (MAF > 1%) present on the risk haplotype in our analyses, with the data supporting the TT>A polymorphic dinucleotide as being responsible for the association with SLE. It is possible that this variant may work in concert with the p.Phe127Cys or p.Ala125Val coding variants to influence both the expression and enzymatic activity of A20, thus producing a more robust functional phenotype. Such a mechanism has been suggested for IRF5, where a complex haplotype is associated with SLE risk 20 .
The location of the TT>A polymorphic dinucleotide in relation to TNFAIP3 suggests that it may be part of a regulatory element, perhaps through recruitment of epigenetic DNA modifiers or through direct interaction with the A20 proximal promoter. The precise mechanism for how the TT>A polymorphism influences TNFAIP3 expression is uncertain, but methods designed to detect long-range interactions of transcriptional regulatory elements may provide insight into this process 21 . Future work will focus on characterizing the protein complex bound to the TT>A polymorphism and on mapping the interactions of this genomic region with other regulatory elements in the vicinity of TNFAIP3.
URLs. UCSC Genome Browser; http://genome.ucsc.edu/; HapMap samples used in this study, ftp.sanger.ac.uk/pub/genevar; R, http:// www.r-project.org/.
METhodS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. The TNFAIP3 coding sequence is available in the RefSeq database under the accession code NP_006281.1.
Note: Supplementary information is available on the Nature Genetics website.
of EMSA bands were performed using a Bio-Rad Universal Hood II Gel Docking Station and Quantity One analysis software. The density value of each band was recorded and normalized to the background for each blot. Statistical analyses were performed using a paired t-test and Prism 5.0 software. A20 protein expression. EBV-transformed B-cell lines were obtained from the Large Lupus Family Registry (OMRF) with IRB approval and selected using genotype data corresponding to the TT>A variant proxy marker rs7749323. Cell lines were maintained in RPMI 1640 supplemented with 10% FBS, penicillin, streptomycin, L-glutamine and 55 µM β-mercaptoethanol. Equal numbers of cells were harvested under basal conditions in log-phase growth and were lysed in RIPA buffer (50 mM Tris, 1% TritonX-100, 150 mM NaCl, 1 mM EDTA, 0.25% deoxycholate and protease inhibitors). Lysates were subjected to SDS-PAGE and protein blot transfer. Membranes were immunoblotted for A20 (Ebioscience) and GAPDH (Imgenex). Bands were revealed radiographically, scanned, and band intensity was analyzed using ImageJ (US National Institutes of Health) software.
